Evaluation of Lu-177 production in the research reactor JRR-3

Fujino, Shunsuke; Hashimoto, Kazuyuki; Saeki, Hideya*; Kawauchi, Yukimasa*; Kawabata, Masako*; Chiba, Yusuke

Lutetium-177 (Lu-177)is a medical radioisotope used in approved radiopharmaceutical "Lutathera" to treat neuroendocrine tumours. And it is one of the promising radionuclides for new therapeutic radiopharmaceuticals. However, Lu-177 is dependent on imports from overseas, and there are concerns that transportation problems etc. may affect domestic distribution and development of new pharmaceuticals. In order to confirm whether JAEA can produce a portion of the Lu-177 for research, we conducted a production test of Lu-177 using JRR-3.

Language	:	Japanese
Journal	:
Volume	:
Number	:
Pages	:
Publication Year/Month	:
Meeting title	:	日本放射化学会第68回討論会(2024)
Held date	:	2024/09
Location (city)	:	静岡
Location (country)	:	日本
Patent information	:
PDF	:
Paper URL	:
DOI for research data	:	Link to research data related to this paper/report.
Keywords	:	Lu-177; RI製造; JRR-3
Research Facility	:	JRR-3M(研究炉3) ;RI製造棟
Press Release	:
Article of JAEA R&D Review	:
Cooperating Institute	:

Accesses	:	- Accesses
Web of Science® Times Cited Count	:	Times Cited Count： If you would like to get the latest times cited, please access the Web of Science®. http://www.webofknowledge.com/wos
InCites™	:
Altmetrics	:

Registration No. : BB20240631
JAEA Abstracts No. :
Paper Submission No. :

[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.